| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Bexarotene | 153559-49-0 | sc-217753 sc-217753A | 10 mg 100 mg | $55.00 $250.00 | 6 | |
Used clinically for the therapeutic purposes helping with cutaneous T-cell lymphoma, bexarotene is a synthetic RXR agonist. | ||||||
9-cis-Retinoic acid | 5300-03-8 | sc-205589 sc-205589B sc-205589C sc-205589D sc-205589A | 1 mg 25 mg 250 mg 500 mg 5 mg | $71.00 $424.00 $3121.00 $5722.00 $148.00 | 10 | |
This is a natural ligand for RXRs. It is also termed alitretinoin. | ||||||
LG 100268 | 153559-76-3 | sc-211737 | 5 mg | $390.00 | 2 | |
A potent and selective RXR agonist that has been extensively studied for its effects on lipid metabolism and cancer. | ||||||
Bexarotene d4 | 2182068-00-2 | sc-353071 | 10 mg | $4000.00 | ||
Bexarotene d4 acts as a selective RXR gamma modulator, characterized by its capacity to stabilize receptor dimers through unique ligand-receptor interactions. This compound exhibits a distinct binding affinity that alters the receptor's conformational dynamics, leading to enhanced transcriptional activity. Its unique hydrophobic characteristics contribute to its interaction with lipid membranes, influencing cellular localization and distribution. Additionally, Bexarotene d4 demonstrates notable stability in various environments, impacting its reactivity and interaction with downstream signaling molecules. | ||||||
SR 11237 | 146670-40-8 | sc-296418 sc-296418A | 5 mg 50 mg | $211.00 $877.00 | ||
This is a potent RXR agonist that has demonstrated anticancer activity in research models. | ||||||